A Pathology Deep Learning System Capable of Triage of Melanoma Specimens Utilizing Dermatopathologist Consensus as Ground Truth

• URL: http://arxiv.org/abs/2109.07554v1
• Date: Wed, 15 Sep 2021 19:48:51 GMT
• Title: A Pathology Deep Learning System Capable of Triage of Melanoma Specimens Utilizing Dermatopathologist Consensus as Ground Truth
• Authors: Sivaramakrishnan Sankarapandian, Saul Kohn, Vaughn Spurrier, Sean Grullon, Rajath E. Soans, Kameswari D. Ayyagari, Ramachandra V. Chamarthi, Kiran Motaparthi, Jason B. Lee, Wonwoo Shon, Michael Bonham, and Julianna D. Ianni
• Abstract summary: We present a pathology deep learning system (PDLS) that performs hierarchical classification of digitized whole slide image (WSI) specimens. We trained the system on 7,685 images from a single lab, including the the largest set of triple-concordant melanocytic specimens compiled to date. We demonstrate that the PDLS is capable of automatically sorting and triaging skin specimens with high sensitivity to Melanocytic Suspect cases.
• Score: 5.46895714413677
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Although melanoma occurs more rarely than several other skin cancers, patients' long term survival rate is extremely low if the diagnosis is missed. Diagnosis is complicated by a high discordance rate among pathologists when distinguishing between melanoma and benign melanocytic lesions. A tool that allows pathology labs to sort and prioritize melanoma cases in their workflow could improve turnaround time by prioritizing challenging cases and routing them directly to the appropriate subspecialist. We present a pathology deep learning system (PDLS) that performs hierarchical classification of digitized whole slide image (WSI) specimens into six classes defined by their morphological characteristics, including classification of "Melanocytic Suspect" specimens likely representing melanoma or severe dysplastic nevi. We trained the system on 7,685 images from a single lab (the reference lab), including the the largest set of triple-concordant melanocytic specimens compiled to date, and tested the system on 5,099 images from two distinct validation labs. We achieved Area Underneath the ROC Curve (AUC) values of 0.93 classifying Melanocytic Suspect specimens on the reference lab, 0.95 on the first validation lab, and 0.82 on the second validation lab. We demonstrate that the PDLS is capable of automatically sorting and triaging skin specimens with high sensitivity to Melanocytic Suspect cases and that a pathologist would only need between 30% and 60% of the caseload to address all melanoma specimens.

Related papers

• Clinical Melanoma Diagnosis with Artificial Intelligence: Insights from a Prospective Multicenter Study [1.2397589403129072]
  AI has proven to be helpful for enhancing melanoma detection. Existing studies are limited by low sample sizes, too homogenous datasets, or lack of inclusion of rare melanoma subtypes. We assessed 'All Data are Ext' (ADAE), an established open-source algorithm for detecting melanomas, by comparing its diagnostic accuracy to that of dermatologists.
  arXiv  Detail & Related papers  (2024-01-25T14:03:54Z)
• Artificial-intelligence-based molecular classification of diffuse gliomas using rapid, label-free optical imaging [59.79875531898648]
  DeepGlioma is an artificial-intelligence-based diagnostic screening system. DeepGlioma can predict the molecular alterations used by the World Health Organization to define the adult-type diffuse glioma taxonomy.
  arXiv  Detail & Related papers  (2023-03-23T18:50:18Z)
• Detection and Localization of Melanoma Skin Cancer in Histopathological Whole Slide Images [1.0962389869127878]
  A projected increase in skin cancer incidents and a dearth of dermatopathologists have emphasized the need for computational pathology (CPATH) systems. This paper proposes a DL method to detect melanoma and distinguish between normal skin and benign/malignant melanocytic lesions in Whole Slide Images (WSI) Our method detects lesions with high accuracy and localizes them on a WSI to identify potential regions of interest for pathologists.
  arXiv  Detail & Related papers  (2023-02-06T18:54:14Z)
• Using Whole Slide Image Representations from Self-Supervised Contrastive Learning for Melanoma Concordance Regression [2.21878843241715]
  Diagnosis is complicated by a high discordance rate among pathologists when distinguishing between melanoma and benign melanocytic lesions. We present a melanoma concordance regression deep learning model capable of predicting the concordance rate of invasive melanoma or melanoma in-situ from digitized Whole Slide Images (WSIs) We trained a SimCLR feature extractor with 83,356 WSI tiles randomly sampled from 10,895 specimens originating from four distinct pathology labs. We achieved a Root Mean Squared Error (RMSE) of 0.28 +/- 0.01 on the test set and a precision and recall of 0.85 +/- 0.05 and 0.61 +/- 0.06, respectively
  arXiv  Detail & Related papers  (2022-10-10T16:07:41Z)
• A Pathologist-Informed Workflow for Classification of Prostate Glands in Histopathology [62.997667081978825]
  Pathologists diagnose and grade prostate cancer by examining tissue from needle biopsies on glass slides. Cancer's severity and risk of metastasis are determined by the Gleason grade, a score based on the organization and morphology of prostate cancer glands. This paper proposes an automated workflow that follows pathologists' textitmodus operandi, isolating and classifying multi-scale patches of individual glands.
  arXiv  Detail & Related papers  (2022-09-27T14:08:19Z)
• Lymphocyte Classification in Hyperspectral Images of Ovarian Cancer Tissue Biopsy Samples [94.37521840642141]
  We present a machine learning pipeline to segment white blood cell pixels in hyperspectral images of biopsy cores. These cells are clinically important for diagnosis, but some prior work has struggled to incorporate them due to difficulty obtaining precise pixel labels.
  arXiv  Detail & Related papers  (2022-03-23T00:58:27Z)
• Assessing glaucoma in retinal fundus photographs using Deep Feature Consistent Variational Autoencoders [63.391402501241195]
  glaucoma is challenging to detect since it remains asymptomatic until the symptoms are severe. Early identification of glaucoma is generally made based on functional, structural, and clinical assessments. Deep learning methods have partially solved this dilemma by bypassing the marker identification stage and analyzing high-level information directly to classify the data.
  arXiv  Detail & Related papers  (2021-10-04T16:06:49Z)
• An Attention-based Weakly Supervised framework for Spitzoid Melanocytic Lesion Diagnosis in WSI [1.0948946179065253]
  Melanoma is an aggressive neoplasm responsible for the majority of deaths from skin cancer. The gold standard for its diagnosis and prognosis is the analysis of skin biopsies. We propose a novel end-to-end weakly-supervised deep learning model, based on inductive transfer learning with an improved convolutional neural network (CNN) The framework is composed of a source model in charge of finding the tumor patch-level patterns, and a target model focuses on the specific diagnosis of a biopsy.
  arXiv  Detail & Related papers  (2021-04-20T10:18:57Z)
• Spectral-Spatial Recurrent-Convolutional Networks for In-Vivo Hyperspectral Tumor Type Classification [49.32653090178743]
  We demonstrate the feasibility of in-vivo tumor type classification using hyperspectral imaging and deep learning. Our best model achieves an AUC of 76.3%, significantly outperforming previous conventional and deep learning methods.
  arXiv  Detail & Related papers  (2020-07-02T12:00:53Z)
• Melanoma Diagnosis with Spatio-Temporal Feature Learning on Sequential Dermoscopic Images [40.743870665742975]
  Existing dermatologists for automated melanoma diagnosis are based on single-time point images of lesions. We propose an automated framework for melanoma diagnosis using sequential dermoscopic images.
  arXiv  Detail & Related papers  (2020-06-19T04:08:22Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.